ESMO 2022 Conference Coverage
ESMO 2022 on Doxorubicin Eluting Embolotherapy for Desmoid Fibromatosis
By
ESMO 2022 Conference Coverage
FEATURING
Eldad Elnekave
By
ESMO 2022 Conference Coverage
FEATURING
Eldad Elnekave
Comments 0
Login to view comments.
Click here to Login
